Serum 25-Hydroxyvitamin D and risk of lung cancer in male smokers: A nested case-control study

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Weinstein, Stephanie J ^a   Yu, Kai ^a   Horst, Ronald L ^b   Parisi, Dominick ^c   Virtamo, Jarmo ^d   Albanes, Demetrius ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Heartland Assays Inc   (United States)

^c INFORMATION MANAGEMENT SERVICES INC   (United States)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

ADULT; ARTICLE; CANCER PREVENTION; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK ASSESSMENT; SEASONAL VARIATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; BLOOD; LUNG TUMOR; MIDDLE AGED; RISK FACTOR; SEASON; SMOKING;

CASE-CONTROL STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS; SEASONS; SMOKING; VITAMIN D;

EID: 79958746222     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020796     Document Type: Article

References (40)

1. IARC (2009) Vitamin D and Cancer Lyon, France International Agency for Research on Cancer.
2. Chung M, Balk EM, Brendel M, Ip S, Lau J, et al. (2009) Vitamin D and Calcium: A Systematic Review of Health Outcomes. Evidence Report No. 183. (Prepared by the Tufts Evidence-based Practice Center under Contract No. HHSA 290-2007-10055-I.) AHRQ Publication No. 09-E015 Rockville, MD Agency for Healthcare Research and Quality.
3. Freedman DM, Looker AC, Chang SC, Graubard BI, (2007) Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 99: 1594-1602.
4. Freedman DM, Looker AC, Abnet CC, Linet MS, Graubard BI, (2010) Serum 25-hydroxyvitamin D and Cancer Mortality in the NHANES III Study (1988-2006). Cancer Res 70: 8587-8597.
5. Kilkkinen A, Knekt P, Heliovaara M, Rissanen H, Marniemi J, et al. (2008) Vitamin D status and the risk of lung cancer: a cohort study in Finland. Cancer Epidemiol Biomarkers Prev 17: 3274-3278.
6. The ATBC Cancer Prevention Study Group (1994) The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study: design, methods, participant characteristics, and compliance. Ann Epidemiol 4: 1-10.
7. Korhonen P, Malila N, Pukkala E, Teppo L, Albanes D, et al. (2002) The Finnish Cancer Registry as follow-up source of a large trial cohort-accuracy and delay. Acta Oncol 41: 381-388.
8. Wagner D, Hanwell HE, Vieth R, (2009) An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem 42: 1549-1556.
9. Gallicchio L, Helzlsouer KJ, Chow WH, Freedman DM, Hankinson SE, et al. (2010) Circulating 25-Hydroxyvitamin D and the Risk of Rarer Cancers: Design and Methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 172: 10-20.
10. Fears TR, Ziegler RG, Donaldson JL, Falk RT, Hoover RN, et al. (2000) Reproducibility studies and interlaboratory concordance for androgen assays in female plasma. Cancer Epidemiol Biomarkers Prev 9: 403-412.
11. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR, (2002) Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30: 771-777.
12. Holick MF, (2007) Vitamin D deficiency. N Engl J Med 357: 266-281.
13. Holick MF, (2009) Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 19: 73-78.
14. Jenab M, Bueno-de-Mesquita HB, Ferrari P, van Duijnhoven FJ, Norat T, et al. (2010) Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ 340: b5500.
15. Weinstein SJ, Yu K, Horst RL, Ashby J, Virtamo J, et al. (2011) Serum 25-hydroxyvitamin D and risks of colon and rectal cancer in Finnish men. Am J Epidemiol 173: 499-508.
16. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, et al. (2008) Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 88: 1519-1527.
17. IOM (Institute of Medicine) (2011) Dietary reference intakes for calcium and vitamin D Washington, DC The National Academies Press.
18. Bikle DD, (2009) Extra renal synthesis of 1,25-dihydroxyvitamin D and its health implications. Clinic Rev Bone Miner Metab 4: 114-125.
19. Jones G, Ramshaw H, Zhang A, Cook R, Byford V, et al. (1999) Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1alpha and CYP24) in human nonsmall cell lung carcinomas. Endocrinology 140: 3303-3310.
20. Grant WB, Mohr SB, (2009) Ecological studies of ultraviolet B, vitamin D and cancer since 2000. Ann Epidemiol 19: 446-454.
21. van der Rhee H, Coebergh JW, Vries ED, (2009) Sunlight, vitamin D and the prevention of cancer: a systematic review of epidemiological studies. Eur J Cancer Prev.
22. Lim HS, Roychoudhuri R, Peto J, Schwartz G, Baade P, et al. (2006) Cancer survival is dependent on season of diagnosis and sunlight exposure. Int J Cancer 119: 1530-1536.
23. Porojnicu AC, Robsahm TE, Dahlback A, Berg JP, Christiani D, et al. (2007) Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role? Lung Cancer 55: 263-270.
24. Zhou W, Heist RS, Liu G, Asomaning K, Neuberg DS, et al. (2007) Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol 25: 479-485.
25. Zhou W, Heist RS, Liu G, Neuberg DS, Asomaning K, et al. (2006) Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 15: 2239-2245.
26. Zhou W, Suk R, Liu G, Park S, Neuberg DS, et al. (2005) Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 14: 2303-2309.
27. Heist RS, Zhou W, Wang Z, Liu G, Neuberg D, et al. (2008) Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. J Clin Oncol 26: 5596-5602.
28. Abnet CC, Chen Y, Chow WH, Gao YT, Helzlsouer KJ, et al. (2010) Circulating 25-Hydroxyvitamin D and Risk of Esophageal and Gastric Cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 172: 94-106.
29. Gallicchio L, Moore LE, Stevens VL, Ahn J, Albanes D, et al. (2010) Circulating 25-Hydroxyvitamin D and Risk of Kidney Cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 172: 47-57.
30. Purdue MP, Freedman DM, Gapstur SM, Helzlsouer KJ, Laden F, et al. (2010) Circulating 25-Hydroxyvitamin D and Risk of Non-Hodgkin Lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 172: 58-69.
31. Zeleniuch-Jacquotte A, Gallicchio L, Hartmuller V, Helzlsouer KJ, McCullough ML, et al. (2010) Circulating 25-Hydroxyvitamin D and Risk of Endometrial Cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 172: 36-46.
32. Zheng W, Danforth KN, Tworoger SS, Goodman MT, Arslan AA, et al. (2010) Circulating 25-Hydroxyvitamin D and Risk of Epithelial Ovarian Cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 172: 70-80.
33. Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, et al. (2010) Circulating 25-Hydroxyvitamin D and Risk of Pancreatic Cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 172: 81-93.
34. Mondul AM, Weinstein SJ, Mannisto S, Snyder K, Horst RL, et al. (2010) Serum vitamin D and risk of bladder cancer. Cancer Res 70: 9218-9223.
35. Wang Y, Jacobs EJ, McCullough ML, Rodriguez C, Thun MJ, et al. (2009) Comparing methods for accounting for seasonal variability in a biomarker when only a single sample is available: insights from simulations based on serum 25-hydroxyvitamin d. Am J Epidemiol 170: 88-94.
36. Karohl C, Su S, Kumari M, Tangpricha V, Veledar E, et al. (2010) Heritability and seasonal variability of vitamin D concentrations in male twins. Am J Clin Nutr 92: 1393-1398.
37. Vieth R, (2009) How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Res 29: 3675-3684.
38. Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, et al. (2010) Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol 171: 903-908.
39. Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E, (2004) Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 15: 255-265.
40. Hofmann JN, Yu K, Horst RL, Hayes RB, Purdue MP, (2010) Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 19: 927-931.